Showing posts with label offering. Show all posts
Showing posts with label offering. Show all posts

Sunday, July 21, 2013

Texas Lawmaker Withdraws Amendment To Punish Universities For Offering LGBT Support

University LGBT resource centers in Texas may be safe for now. Thursday night, state Rep. Bill Zedler (R) withdrew his amendment to the appropriations bill that would have cut funding for any public universities that provided support service for LGBT students. Zedler did not explain his decision to withdraw, but his actions mirror those of Rep. Wayne Christian (R) who proposed then withdrew a similar measure in 2011.

Zedler’s bill not-so-subtly suggested that homosexuality directly causes disease:

An institution of higher education may not use money appropriated to the institution under this Act, or any property or facility of the institution funded by appropriations under this Act, to support, promote, or encourage any behavior that would lead to high risk behavior for AIDS, HIV, Hepatitis B, or any sexually transmitted disease.

Though Zedler’s amendment is not advancing, efforts are still underway to undermine the support for LGBT students, particularly at Texas A&M University, where students are attempting to opt-out of funding the campus’s center on religious grounds.


View the original article here

Monday, March 4, 2013

Keryx announces $55M public offering

NEW YORK -- Keryx Biopharmaceuticals Inc. said Tuesday that it will offer $55 million worth of its common stock in a public offering.

The drugmaker is studying an experimental drug, Zerenex, as a treatment for late-stage kidney disease. The company said it would use proceeds of the offering to fund prelaunch activities for the drug.

Keryx has no products on the market, and Zerenex is its most advanced drug. The company plans to submit an application for approval of the drug to both the U.S. Food and Drug Administration and European regulators in this year's second quarter.

The company has granted underwriters a 30-day option to purchase additional shares of common stock.

JP Morgan is acting as the book-running manager for the offering.

Company shares rose $2.30, or 38 percent, to close at $8.36 in regular trading. In afterhours trading shares fell 21 cents, or 2.5 percent to $8.15.


View the original article here